國家衛生研究院 NHRI:Item 3990099045/11921
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 914926      線上人數 : 1427
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11921


    題名: Trends and factors in antipsychotic use of outpatients with anxiety disorders in Taiwan, 2005-2013: A population-based study
    作者: Huang, CW;Chiu, YW;Chen, PJ;Yu, NW;Tsai, HJ;Chang, CM
    貢獻者: Institute of Population Health Sciences
    摘要: AIM: Antipsychotics off-label use is common in clinical practice but information is limited to reveal the trends of antipsychotic use in specific mental disorder in Taiwan. This study aimed to examine the trends and associated factors of antipsychotic use among outpatients with anxiety disorders in Taiwan during 2005-2013. METHODS: We assessed the annual prescriptions of antipsychotic use in 9 consecutive years (2005-2013) using the National Health Insurance Research Database among adults (aged >/=18 years) with anxiety disorders in outpatient visits in Taiwan. We applied logistic regression to examine the trends and associated factors of antipsychotic use. RESULTS: The proportion of antipsychotic medication use for anxiety disorder increased from 8.4% in 2005 to 9.1% in 2013. First-generation antipsychotics (FGAs) use is more than that of second-generation antipsychotics (SGAs) in patients with anxiety disorder through the 9-year period. Sulpiride and flupentixol were the two-most common FGAs in the treatment of anxiety disorder. Patients with specific anxiety disorder (traumatic stress disorder, panic disorder/agoraphobia, generalized anxiety disorder, and obsessive compulsive disorder), female gender, younger adult (age <65 years), comorbidity with major depression or minor depression, antidepressants concurrent use and visits to psychiatrists, medical centers and primary care were significantly tended to prescribe antipsychotics. CONCLUSION: Antipsychotic off-label use significantly increased among patients with anxiety disorder in this national representative cohort. Such increased use of antipsychotics could be driven by augmentation of their prescription for major depression. As their efficacy and safety remain uncertain, further study is warranted.
    日期: 2019-08
    關聯: Psychiatry and Clinical Neurosciences. 2019 Aug;73(8):501-507.
    Link to: http://dx.doi.org/10.1111/pcn.12861
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1323-1316&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000478903200010
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85067349063
    顯示於類別:[蔡慧如] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB31077503.pdf1249KbAdobe PDF342檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋